Standout Papers

Irisin ameliorates doxorubicin-induced cardiac perivascular fibrosis through inhibiting endothelial-to-mesenchyma... 2021 2026 2022 2024133
  1. Irisin ameliorates doxorubicin-induced cardiac perivascular fibrosis through inhibiting endothelial-to-mesenchymal transition by regulating ROS accumulation and autophagy disorder in endothelial cells (2021)
    Jianan Pan, Hui Zhang et al. Redox Biology

Immediate Impact

55 standout
Sub-graph 1 of 25

Citing Papers

Tailoring traditional Chinese medicine in cancer therapy
2025 Standout
Precision nanomedicine: navigating the tumor microenvironment for enhanced cancer immunotherapy and targeted drug delivery
2025 Standout
2 intermediate papers

Works of Lin Gao being referenced

The Imbalance of p53–Park7 Signaling Axis Induces Iron Homeostasis Dysfunction in Doxorubicin‐Challenged Cardiomyocytes
2023
Irisin ameliorates doxorubicin-induced cardiac perivascular fibrosis through inhibiting endothelial-to-mesenchymal transition by regulating ROS accumulation and autophagy disorder in endothelial cells
2021 Standout

Author Peers

Author Last Decade Papers Cites
Lin Gao 288 124 88 235 41 703
Colin Davenport 144 94 50 259 49 802
Agnès Ribes 172 78 65 184 43 638
Ming‐Shian Tsai 252 70 118 265 45 778
Ellen Thompson 214 54 85 195 37 738
Hans Olivecrona 175 121 142 199 34 793
Tjin‐Shing Jap 208 86 32 292 34 839
A Kolín 177 109 113 193 46 829
Elena Doldo 137 88 86 277 28 805
Baimeng Zhang 165 66 67 162 31 600
Zhuo Li 261 89 241 163 36 847

All Works

Loading papers...

Rankless by CCL
2026